5 Things You'll Want to Watch With GW Pharmaceuticals

GW Pharmaceuticals (NASDAQ: GWPH) ranks as one of the best-performing biotech stocks of 2019 so far. Its share price has soared more than 80% thanks to a tremendously successful U.S. launch for cannabidiol (CBD) drug Epidiolex in treating Dravet syndrome and Lennox-Gastaut syndrome (LGS).